Benzinga - Fri, 05 Mar 2021 06:37:42 -0400
Benzinga - Thu, 04 Mar 2021 13:11:10 -0400
Benzinga - Thu, 04 Mar 2021 11:10:08 -0400
Benzinga - Thu, 04 Mar 2021 09:11:14 -0400
Benzinga - Thu, 04 Mar 2021 08:35:45 -0400
Benzinga - Thu, 04 Mar 2021 08:01:05 -0400
Benzinga - Thu, 04 Mar 2021 07:17:50 -0400
Benzinga - Thu, 04 Mar 2021 06:04:05 -0400
Benzinga - Wed, 03 Mar 2021 17:37:27 -0400
Benzinga - Wed, 03 Mar 2021 15:30:57 -0400
Benzinga - Wed, 03 Mar 2021 13:52:51 -0400
Benzinga - Wed, 03 Mar 2021 13:40:13 -0400
Benzinga - Wed, 03 Mar 2021 13:12:58 -0400
Benzinga - Wed, 03 Mar 2021 13:03:05 -0400
Benzinga - Wed, 03 Mar 2021 12:02:02 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that believe will be improved versions of widely prescribed, approved drugs. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety. KemPharm's two lead product candidates are KP415, ER d-threo-methylphenidate product candidate for the treatment of ADHD, and KP201/IR, APAP-free, single-entity, benzhydrocodone hydrochloride IR abuse-deterrent product candidate designed for the treatment of acute pain.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KMPHKemPharm4.36%189.4M

KemPharm Company Questions & Answers

Q

How do I buy KemPharm (KMPH) stock?

A

You can purchase shares of KemPharm (NASDAQ: KMPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are KemPharm's (KMPH) main competitors?

A

Other companies in KemPharm’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX) and Lipocine (NASDAQ:LPCN).

Q

What is the target price for KemPharm?

A

The latest price target for KemPharm (NASDAQ: KMPH) was reported by HC Wainwright & Co. on 2021-03-04. The analyst firm set a price target for 12.00 expecting KMPH to rise to within 12 months (a possible 19.40% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is KemPharm (KMPH) stock ?

A

The stock price for KemPharm (NASDAQ: KMPH) is $10.05 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next KemPharm (KMPH) dividend?

A

There are no upcoming dividends for KemPharm.

Q

When is KemPharm (NASDAQ:KMPH) reporting earnings?

A

There are no earnings for KemPharm

Q

When is the upcoming split for KMPH?

A

There is no upcoming split for KemPharm.